Vol. 3 No. 11 (2025), Articles
Vol. 3 No. 11 (2025)

THE ROLE OF IMMUNOLOGICAL MECHANISMS IN VACCINE DEVELOPMENT: A SYSTEMATIC ANALYSIS

Articles
Published 2025-12-13
Kholiqberdiyeva Zebo
Student of Tashkent State Medical University
PDF
DOI

Keywords

vaccine immunology, antigen presentation, adjuvants, B-cell response, T-cell response, immunological memory, vaccine platforms, correlates of protection, public health, WHO.

How to Cite

THE ROLE OF IMMUNOLOGICAL MECHANISMS IN VACCINE DEVELOPMENT: A SYSTEMATIC ANALYSIS. (2025). MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE, 3(11), 77-84. https://universalpublishings.com/index.php/mpttp/article/view/15201
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This scientific article provides a comprehensive analysis of the fundamental immunological mechanisms that underpin modern vaccine development. The main objective of the research is to deconstruct the complex interplay between vaccine components and the host immune system, elucidating the pathways that lead to the development of robust and lasting protective immunity. The research analyzes how different vaccine platforms—including live-attenuated, inactivated, subunit, viral vector, and mRNA vaccines—leverage specific immunological pathways to achieve their goals. The results demonstrate that the efficacy of a vaccine is not merely a function of the antigen, but of a precisely engineered immunological dialogue that guides the immune system towards a safe and effective protective response. The article concludes with perspectives on future directions, including universal vaccine platforms and the application of systems immunology to predict vaccine efficacy.

PDF
DOI

References

1.Plotkin, S. A., Orenstein, W. A., & Offit, P. A. (Eds.). (2017). Plotkin's Vaccines (8th ed.). Elsevier.

2.Pulendran, B., & Ahmed, R. (2011). Immunological mechanisms of vaccination. Nature Immunology, 12(6), 509–517.

3.Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines — a new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261–279.

4.Crotty, S. (2019). T Follicular Helper Cell Biology: A Decade of Discovery and Diseases. Immunity, 50(5), 1132–1148.

5.Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018). Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Seminars in Immunology, 39, 14-21.

6.Sette, A., & Crotty, S. (2021). Adaptive immunity to SARS-CoV-2 and COVID-19. *Cell*, 184(4), 861–880.

7.World Health Organization. (2020). Immunization Agenda 2030: A Global Strategy to Leave No One Behind. World Health Organization.

8.O'Hagan, D. T., Lodaya, R. N., & Lofano, G. (2020). The continued advance of vaccine adjuvants – ‘we can work it out’. Seminars in Immunology, 50, 101426.

9.Plotkin, S. A. (2010). Correlates of protection induced by vaccination. Clinical and Vaccine Immunology, 17(7), 1055–1065.

10.Polack, F. P., et al. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine, 383, 2603-2615.